When you hear about the commercialization of space, it is not only the efforts of Blue Origin, Virgin Galactic, or Elon Musk’s SpaceX to provide civilian space flights. If DARPA has anything to do with it, there will also be the “development and future realization of biomanufacturing capabilities in space.” The timeline for a private sector role in the commercialization of these biotechnology capabilities is unclear, but DARPA has begun to explore the possibilities the DARPA way.
Space has many strategic vectors: economic, military, cyber, and information warfare. It will play a vital role in the future of U.S. collaboration with its allies. Space is also on the list of domains that are part of The Chinese Dream for supremacy in areas like quantum computing and artificial intelligence. As China sees it, the U.S. could stand in the way of achieving its strategic aims in space. Classic deterrence theory (i.e., nuclear proliferation and deterrence) should be applied to these space-based challenges.
The Federal Communications Commission is planning to vote on a proposal to make spectrum available for the first time to enable commercial space launches. The FCC is set to vote on the proposal this month. The proposal would make 2021 shaped to be a record-setting year for commercial space launches.
On Thursday, NASA announced that it has selected three US companies to develop and perfect human landing technologies for the agencies Artemis program. The three companies are SpaceX, Blue Origin, and Dynetics. According to NASA, the first woman and next man will travel to the moon’s surface by using this
AFWERX, the Air Force’s innovation startup, has announced that it is accepting submissions for nine new projects meant to further space developments and technology. This represents its biggest call for solutions to date. The initiatives, Base of the Future and the Space initiative, encompass five challenge areas and four respectively.